1 / 4

Autologous Matrix-Induced Chondrogenesis (AMIC) Market to Record an Impressive Growth Rate US$ 186.4 Mn by 2024

Autologous Matrix-Induced Chondrogenesis (AMIC) Market is Expected to Register Highest CAGR of 8.6% During 2016-2024

aarti
Download Presentation

Autologous Matrix-Induced Chondrogenesis (AMIC) Market to Record an Impressive Growth Rate US$ 186.4 Mn by 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Global Market Study on Autologous Matrix-Induced Chondrogenesis (AMIC): Polyethylene Glycol (PEG) Segment Expected to Grow with a Healthy CAGR over the Forecast Period

  2. P e r s i s t e n c e M a r k e t R e s e a r c h About Us Persistence Market Research (PMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge. Each PMR Syndicated Research report covers a different sector - such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With a wider scope and stratified research methodology, our syndicated reports strive to serve clients and satisfy their overall research requirement. Copyright © 2015 Persistence Market Research All Rights Reserved. This document contains highly confidential information and is the sole property of PMR. No part of it may be circulated, copied, quoted, or otherwise reproduced without the approval of PMR. Autologous Matrix-Induced Chondrogenesis (AMIC) Market 2016 - 2024

  3. P e r s i s t e n c e M a r k e t R e s e a r c h Report Media Releases Autologous Matrix-Induced Chondrogenesis (AMIC) Market Estimated to Register a CAGR of 8.6% Between 2016 and 2024; Increasing Demand for Articular Cartilage Repair Expected to Boost Market Revenue Growth Persistence Market Research delivers key insights on the global Autologous Matrix-Induced Chondrogenesis (AMIC) Market in its upcoming report titled, “Autologous Matrix-Induced Chondrogenesis (AMIC) Market: Global Industry Analysis and Forecast, 2016–2024”. In terms of revenue, the global AMIC market is projected to register a CAGR of 8.6% over the forecast period owing to various factors, on which Persistence Market Research offers detailed insights and forecasts. The global Autologous Matrix-Induced Chondrogenesis market value in 2016 is estimated to be US$ 96.11 Mn and this is expected to increase to US$ 186.4 Mn by the end of 2024. Request to view Sample Report @ http://www.persistencemarketresearch.com/samples/12271 Autologous Matrix-Induced Chondrogenesis (AMIC) is a biological treatment method to repair articular cartilage damage. AMIC therapy is a step wise process. Micro fracture surgery is followed by application of a bi-layer collagen I/III membrane. It slows down cartilage degeneration with an intent to avoid or delay partial or total joint replacement (e.g. knee replacement) surgery. The indications for AMIC includes Grade III or IV chondral lesions with lesion size of about 2 cm2 to 8cm2. Growth of the global Autologous Matrix-Induced Chondrogenesis market is mainly driven by increasing demand for minimally invasive procedures, rising prevalence of bone and joint disorders and a surge in sports injuries. Another prominent growth driver is the faster uptake and access along with affordable pricing. However, lack of clinical data and lack of efficient reimbursement is expected to restrain growth of the market over the forecast period. The market is segmented based on material type and regions. Based on material type, the market is segmented into Hyaluronic Acid, Collagen, Polyethylene glycol (PEG), polylactic-co- glycolic acid (PGLA) and others. The PEG segment is expected to grow with a healthy CAGR over the forecast period, owing to its ability to be gelled into complex defects in situ using UV-light. The segment is expected to register a significant CAGR of 11.1 % during the forecast period. The Others segment, which includes PLLA, agarose-alginate, chitosan, poly (ester- ether) polydioxanone, etc. is anticipated to grow with a CAGR of 8.1%. Segments such as hyaluronic acid and collagen are expected to register a CAGR of 8.9% and 8.2% respectively Autologous Matrix-Induced Chondrogenesis (AMIC) Market 2016 - 2024

  4. P e r s i s t e n c e M a r k e t R e s e a r c h over the forecast period. The PGLA segment is expected to witness a CAGR of 9.2% over the forecast period. This report assesses trends that drive growth of each segment on the global as well as regional levels and offers potential takeaways that could prove substantially useful to surgical products manufacturing companies that wish to enter the global Autologous Matrix-Induced Chondrogenesis (AMIC) market. North America is anticipated to dominate the global Autologous Matrix-Induced Chondrogenesis (AMIC) market with maximum market share in 2016. North America is expected to account for more than 38% of the total Autologous Matrix-Induced Chondrogenesis (AMIC) market share in terms of value in 2016. Followed by North America, Europe is one of the established markets for AMIC. Europe contributes to around 34% of the total market share in 2016. Among emerging markets, Asia Pacific is estimated to exhibit the highest CAGR of 10.3% over the forecast period, due to higher adoption of AMIC procedures in the region. Request to view Table of content @ http://www.persistencemarketresearch.com/market- research/autologous-matrixinduced-chondrogenesis-market/toc Some key players in the global Autologous Matrix-Induced Chondrogenesis (AMIC) market identified in the report include Anika Therapeutics, Inc., Arthro-Kinetics, B. Braun Melsungen AG, BioTissue AG, CartiHeal, Geistlich Pharma AG, JRI Orthopaedics Ltd., Matricel GmbH, Smith & Nephew plc, and Zimmer Biomet Holdings. Persistence Market Research has discussed individual strategies of these companies in terms of increasing focus on overcoming major hindrances through innovation and enhancing the distribution base. The report concludes with strategic recommendations for players already present in the market and new players planning to enter the global Autologous Matrix-Induced Chondrogenesis (AMIC) market. For information regarding permissions, contact: Persistence Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 Email: sales@persistencemarketresearch.com Website: http://www.persistencemarketresearch.com/ media@persistencemarketresearch.com Autologous Matrix-Induced Chondrogenesis (AMIC) Market 2016 - 2024

More Related